Vericel Corp Ord

VCEL · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

9 USD

Margin of Safety

-427.1 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Vericel Corp is a commercial biotherapy company that develops and markets autologous cell therapy products for severe cartilage and skin defects, with revenue growth driven primarily through volume expansion in existing medical institutions as well as the development of new treatment centers.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.